Complete guide to cannabis laws, penalties, and travel advice
Lesotho occupies an extraordinary and paradoxical position in global cannabis policy. This small, mountainous kingdom entirely surrounded by South Africa became in 2017 the first country on the African continent to issue a licence for medical cannabis cultivation — a landmark decision that sparked a wave of international investment interest and established Lesotho as a pioneering jurisdiction in African drug policy reform.
The licensing decision was driven primarily by economic development logic rather than public health philosophy. Lesotho is one of the world's least economically developed nations, with GDP per capita among the lowest globally, extreme unemployment, and a healthcare system stretched by HIV prevalence rates exceeding 20% in the adult population. Cannabis — known locally as matekoane — has been cultivated by Basotho highland farmers for generations, primarily for informal local markets and cross-border trade into South Africa. Rather than continuing to criminalise an industry that already existed, the Lesotho Ministry of Health chose to license and regulate it for medical and pharmaceutical export purposes.
The legal framework governing medical cannabis cultivation is the Drugs of Abuse Act of 2008, supplemented by Ministry of Health regulations and specific licence conditions. The Act technically prohibits personal use, possession for personal use, and non-licensed cultivation, but enforcement in rural highland areas — where cannabis grows openly in village fields — has always been minimal. The practical reality for Lesotho residents is that cannabis use is tolerated by community-level policing structures while the formal legal prohibition remains on the books.
No recreational legalisation framework exists. Lesotho's government has not publicly stated any intention to legalise recreational cannabis, and discussions remain focused on the agricultural export and pharmaceutical manufacturing opportunity rather than personal freedom questions.
Under the Drugs of Abuse Act 2008, possession of cannabis for personal use is a criminal offence in Lesotho. However, the enforcement of this provision is highly inconsistent across the country. In urban Maseru and at formal border crossings with South Africa, enforcement is notably more active than in highland agricultural communities where cannabis is a traditional crop.
| Offence Category | Context / Quantity | Enforcement Reality | Maximum Penalty |
|---|---|---|---|
| Personal possession (rural) | Small amounts | Rarely enforced | Fine / 2 years |
| Personal possession (urban/border) | Any amount | Moderate enforcement | Fine / 2 years |
| Supply / Dealing | Commercial intent | Prosecuted | 5 years |
| Trafficking | Cross-border / large scale | Actively prosecuted | 10 years |
| Licensed medical cultivation | Ministry of Health licence | Fully legal | No penalty |
The Lesotho Mounted Police Service (LMPS) is responsible for narcotics enforcement. Resource limitations mean that large-scale enforcement of personal use laws in rural communities is not operationally feasible, creating a de facto tolerance zone in highland farming areas despite the formal legal prohibition.
Lesotho's medical cannabis licensing programme operates through the Ministry of Health. Licences cover cultivation, processing, and export of cannabis for pharmaceutical, medical, and scientific purposes. The regulatory framework established in 2017 has been progressively refined, with new licensing guidelines issued in 2019 and 2021.
International companies that have secured cultivation licences in Lesotho include a range of Southern African and multinational cannabis businesses attracted by Lesotho's key competitive advantages: altitude (1,400–3,400 metres above sea level providing high UV intensity for cannabinoid production), clean water from the Highlands Water Project, relatively low land and labour costs, and proximity to South Africa's pharmaceutical sector.
The cannabis produced under Lesotho's licensed programme is intended primarily for export to regulated markets in Germany, the United Kingdom, and other jurisdictions with import demand for GMP-certified medical cannabis. Domestic patient access through the medical programme is not yet a structured offering — the country has no licensed domestic medical dispensary network.
Quality challenges have emerged for some licence holders: achieving consistent GMP certification for outdoor-grown cannabis from smallholder networks has proved technically demanding. The Ministry of Health has worked with international consultants to build capacity for certification and export compliance.
In Lesotho, a distinction exists between licensed commercial cultivation (legal since 2017) and traditional informal cultivation (technically illegal but tolerated). The highlands of Lesotho have some of the world's highest cannabis cultivation rates per capita. Villages in the Mokhotlong, Thaba-Tseka, and Qacha's Nek districts are known internationally for their cannabis production, which has supported rural livelihoods for decades.
The licensing framework offers a potential pathway for traditional cultivators to formalise their operations, participate in licensed cooperatives, and access premium export markets. Several social enterprise models have been proposed — and a few initiated — to bring subsistence cannabis farmers into the licensed supply chain, though the commercial and logistical complexity of this transition has proved challenging.
Unlicensed commercial-scale cultivation — particularly grow operations targeting the South African black market rather than domestic subsistence — is more likely to attract law enforcement attention. The LMPS cooperates with South African Police Service (SAPS) on cross-border narcotics suppression operations.
Lesotho is a source country for cannabis entering South Africa's substantial informal market. The 864-kilometre border between Lesotho and South Africa — the longest landlocked-country border in Southern Africa — is only partially monitored, and cross-border cannabis trafficking is significant. South African SAPS operations targeting Lesotho-origin cannabis are conducted regularly, with cooperation from LMPS.
For individuals caught trafficking cannabis across the Lesotho-South Africa border: Lesotho-side prosecution leads to up to 10 years imprisonment under the Drugs of Abuse Act. South Africa-side prosecution falls under South Africa's Drugs and Drug Trafficking Act, which carries similar maximum penalties. Individuals can face prosecution in either or both jurisdictions depending on where they are apprehended.
Cannabis cultivation in Lesotho's highlands is as deeply embedded in rural culture as any agricultural practice. The Basotho people have cultivated matekoane for recreational, social, and rudimentary medicinal purposes for at least two centuries. Cannabis is woven into highland village social life: it is smoked by shepherds tending flocks on mountain plateaux, shared during communal work gatherings, and used in certain traditional healing contexts.
The plant's integration into Basotho culture is reflected in the widely held community view that cannabis use is not a criminal or moral transgression — a perspective that sits in direct tension with the formal legal prohibition but has historically shaped the practical tolerance of authorities. This cultural reality was a significant factor in the 2017 decision to license medical cultivation rather than escalate prohibition enforcement.
International media coverage following the 2017 licensing decision brought significant attention to Lesotho, framing it as a potential model for African cannabis policy reform. This coverage stimulated interest from investors, journalists, and cannabis industry professionals, making Lesotho a destination of modest cannabis-related tourism interest — though no licensed cannabis tourism infrastructure exists.
Lesotho is a relatively low-risk destination for cannabis-related encounters in most contexts, but specific locations require heightened caution. The country's primary entry points — Maseru Bridge crossing and Moshoeshoe I International Airport — are where formal enforcement is most actively applied.
There are multiple road border crossings between Lesotho and South Africa. The Maseru Bridge crossing is the busiest and has active South African Border Management Authority (BMA) presence on the South African side and LMPS presence on the Lesotho side. Both conduct vehicle and luggage searches. Cannabis found during border crossing is treated as trafficking regardless of quantity — both Lesotho and South African authorities apply this interpretation.
In Maseru, cannabis is available through informal channels but is not openly visible in the way it is in rural highland areas. Police in Maseru apply laws more actively than in the countryside. Tourists should not attempt to purchase or use cannabis in the capital.
In the highland districts, cannabis is openly cultivated and used with minimal police interference. Foreign travelers visiting highland areas for hiking or cultural tourism are unlikely to encounter law enforcement related to cannabis. However, this tolerance is directed at Basotho community members — a foreign national caught purchasing or using cannabis in these areas still technically faces prosecution under Lesotho law.
Lesotho's medical cannabis licensing programme has continued to evolve since its establishment. In 2021, the Ministry of Health revised licensing fees and application procedures to make the programme more accessible to smaller domestic operators, responding to criticism that the initial framework primarily benefited international companies over local farmers. Several cooperative models linking smallholder highland cultivators with licensed processing facilities have been approved.
Discussions within SADC (Southern African Development Community) about regional cannabis policy harmonisation have been ongoing, with Lesotho, Zambia, and Zimbabwe all having taken regulatory steps toward licensed medical cannabis. These regional dynamics may influence Lesotho's evolution toward a more formalised domestic access framework in the future.
South Africa's cannabis for private purposes reform (following the Constitutional Court's 2018 ruling in the Prince case) has had a spillover cultural effect in Lesotho, increasing public discussion of personal use tolerance. No legislative reform of personal use provisions has occurred in Lesotho as of the current review date.
Lesotho's medical cannabis licensing programme attracted immediate international interest following the 2017 pioneer licence. Companies from South Africa, Canada, the United Kingdom, Germany, Australia, and Israel have either secured licences, entered joint ventures with local partners, or conducted feasibility assessments for Lesotho operations. The appeal is clear: Lesotho offers altitude-driven high UV intensity that stimulates cannabinoid synthesis, year-round outdoor growing conditions in some elevation bands, established water access through the Highlands Water Project infrastructure, and a government demonstrably willing to engage with the international medical cannabis industry.
The primary export targets have been Germany (which became the world's largest medical cannabis import market following its 2017 medical legalisation), the United Kingdom (whose medical cannabis market expanded significantly after 2018), and Australia (which legalised medical cannabis in 2016 and imports significant volumes). Meeting the import standards of these markets — particularly GMP (Good Manufacturing Practice) certification under EU and TGA (Australian Therapeutic Goods Administration) frameworks — has been the primary technical challenge for Lesotho operators.
Several Lesotho cultivation operations have achieved GMP certification or are in the process of doing so. These include both dedicated pharmaceutical-grade indoor facilities and hybrid outdoor-indoor operations in the Maseru district and surrounding highlands. The Lesotho Revenue Authority has developed specific tax and customs procedures for cannabis export consignments, reflecting the growing commercial reality of the sector.
The economic development argument for scaling the sector further is compelling: cannabis cultivation generates substantially higher per-hectare revenue than traditional Lesotho food crops such as sorghum, wheat, or maize. If the export framework scales as projected, licensed cannabis could become a meaningful contributor to Lesotho's foreign exchange earnings and rural employment, particularly in highland districts with limited agricultural diversification options. Development economists and international NGOs working in Lesotho have highlighted this potential while also noting risks of market concentration and the importance of ensuring smallholder farmers — not only foreign investors — benefit from the sector's growth.
Yes. In 2017, Lesotho became the first country in Africa to issue a medical cannabis cultivation licence when the government granted a licence to Verve Dynamics. This made Lesotho a pioneer in African cannabis policy and attracted significant international investment interest.
Personal use is technically illegal under the Drugs of Abuse Act 2008 but widely tolerated in practice especially in rural highland areas where cannabis has been cultivated for generations. There are no formal decriminalisation provisions and enforcement is highly inconsistent by region.
No. There is no legal framework permitting recreational cannabis use by tourists or residents. While rural enforcement is lax, cannabis is not legally available for tourists and enforcement at Maseru border crossings and the international airport is stricter.
Lesotho has significant potential as a medical cannabis exporter due to its high altitude, clean water, traditional cultivation knowledge, and low production costs. Multiple international companies hold cultivation licences. Export market development to Germany and the UK is progressing, though GMP certification challenges remain.